Advinus meets milestone in drug discovery alliance

Advinus Therapeutics, the TATA promoted pharmaceutical R&D Company, announced that it has received the second milestone in its R&D collaboration with Takeda Pharmaceutical


(Photo Courtesy:

The achievement of this milestone substantiates the successful path of the collaboration and confirms Advinus' proven strength in providing innovative solutions with speed and quality - essential ingredients for discovery of safe and effective medicines.

A payment of $3 million has been made by Takeda to Advinus to mark the achievement.

In October 2012, Advinus and Takeda announced a multi-year multi-project collaboration in the area of drug discovery.

In this collaboration, Advinus is responsible for carrying out all the research required to identify candidate molecules for clinical development in several therapeutic areas while Takeda is responsible for the development and commercialization of these candidates.

In October 2013, Advinus met the milestone that was set to mark the end of the first year of the collaboration.


Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email